Bank of New York Mellon Corp
BankPosition in AVIR — Atea Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in AVIR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$880,951
-$118,679 QoQ
Shares Held
189,452
+2.0% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. AVIR ranks #201 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $880,951 | 189,452 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $999,630 | 185,805 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $708,512 | 198,463 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $601,697 | 207,482 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $720,543 | 200,151 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $607,315 | 203,116 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $710,299 | 212,030 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $712,510 | 212,690 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $881,067 | 266,184 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $967,809 | 239,557 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $778,627 | 255,288 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $964,224 | 321,408 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,201,679 | 321,305 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,037,021 | 309,559 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,541,825 | 320,546 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,746,009 | 306,856 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,917,312 | 270,044 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,997,961 | 276,726 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,483,468 | 277,793 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,090,145 | 259,274 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $4,215,987 | 196,275 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,731,634 | 44,237 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,538,297 | 36,819 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||